Evidence map›Paper›PMID 29705821›Full record

ArticleEuropean journal of clinical pharmacology2018

Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance.

Pier Giorgio Cojutti, Cristina Barbarino, Amato De Monte, William Hope, Federico Pea

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Pier Giorgio CojuttiInstitute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital of Udine, Azienda Sanitaria Universitaria Integrata di Udine, P.le S. Maria della Misericordia 3, 33100, Udine, Italy.
Cristina BarbarinoDepartment of Anaesthesia and Intensive Care, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
Amato De MonteDepartment of Anaesthesia and Intensive Care, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
William HopeAntimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Federico PeaInstitute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital of Udine, Azienda Sanitaria Universitaria Integrata di Udine, P.le S. Maria della Misericordia 3, 33100, Udine, Italy. federico.pea@asuiud.sanita.fvg.it.ORCID http://orcid.org/0000-0002-6966-7167
Ospedale Santa Maria della Misericordia di Udine · ITUniversity of Udine · ITUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCerebral HemorrhageDose-Response Relationship, DrugFemaleHumansKidneyKidney Function TestsLinezolidMeropenemMiddle AgedAnti-Bacterial AgentsLinezolidMeropenem

Identifiers

PMID29705821
OpenAlexW2801585534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.